WU; Yibing

Patent Applications and Registrations

Patent applications and USPTO patent grants for WU; Yibing.The latest application filed is for "a life maintenance mode, a brain inhibition therapy and a personal health information platform".

Company Profile

0.4.13

WU; Yibing - Beijing CN
WU; Yibing - US
Wu; Yibing - Shijiazhuang N/A CN
Wu; Yibing - Snyder NY
Wu; Yibing - Wellesley MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
A Life Maintenance Mode, A Brain Inhibition Therapy And A Personal Health Information Platform App 20170112407 - WU; Yibing	2017-04-27
Life Maintenance Mode, A Brain Inhibition Therapy And A Personal Health Information Platform App 20170112392 - WU; Yibing	2017-04-27
Life Maintenance Mode, A Brain Inhibition Therapy And A Personal Health Information Platform App 20170086698 - WU; Yibing	2017-03-30
Life Maintenance Mode, A Brain Inhibition Therapy And A Personal Health Information Platform App 20170087301 - WU; Yibing	2017-03-30
A Life Maintenance Mode, A Brain Inhibition Therapy And A Personal Health Information Platform App 20160081575 - WU; Yibing	2016-03-24
Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof Grant 8,796,285 - Zhang , et al. August 5, 2	2014-08-05
Methods of using combined forward and backward sampling of nuclear magnetic resonance time domain for measurement of secondary phase shifts, detection of absorption mode signals devoid of dispersive components, and/or optimization of nuclear magnetic resonance experiments Grant 8,248,071 - Szyperski , et al. August 21, 2	2012-08-21
Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof App 20120088775 - Zhang; Hailin ; et al.	2012-04-12
Methods Of Using Combined Forward And Backward Sampling Of Nuclear Magnetic Resonance Time Domain For Measurement Of Secondary Phase Shifts, Detection Of Absorption Mode Signals Devoid Of Dispersive Components, And/or Optimization Of Nuclear Magnetic Resonance Experiments App 20090230959 - Szyperski; Thomas ; et al.	2009-09-17
Transcriptional activator comprising a short hydrophobic activation peptide Grant 7,087,711 - Ptashne , et al. August 8, 2	2006-08-08
Transcriptional activation system, activators, and uses therefor App 20040014036 - Ptashne, Mark ; et al.	2004-01-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.